Palvella Therapeutics

PVLANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.210 B

$153.41 +1.89%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$41.7M

Loss-making

Shares outstanding

14,408,407

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#97Generate BiomedicinesGENB$2.23B
#98Prestige Consumer HealthcarePBH$2.22B
#99Palvella TherapeuticsPVLA$2.21B
#100Aurinia PharmaceuticalsAUPH$2.21B
#101Ocular TherapeutixOCUL$2.19B

What if Palvella Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$2,101,138

Per share 13,696× higher

Bitcoin $1.72T

$119,361.13

Per share 778× higher

Nvidia $5.48T

$380,323.65

Per share 2,479× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Palvella Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.